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Background
Cardiovascular Magnetic Resonance (CMR) is known to
offer additional morphologic information in Hypertrophic
Cardiomyopathy (HCM). CMR based myocardial tissue
differentiation and the detection of small morphological
details is of proven clinical value. MR at a magnetic field
strength of 7 Tesla holds the promise to enhance spatial
resolution and anatomical detail, but is currently primarily
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Figure 1 Case example with myocardial crypts- hyperintense signal displays at LGE-images is partly explained by blood. A-B: LGE-imaging at 3T.
C-D: CINE GRE at 7T
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used in brain imaging [1]. CMR at 7.0T has been applied
in healthy volunteers [2,3]. Here we examine the feasibility
of CMR at 7T in patients and demonstrate its capability
for the visualization of subtle morphological details which
are elusive in today’s clinical CMR practice.
Methods
We screened 131 patients with HCM. 13 Patients with
HCM (9 male, 56 ±31 years) and 13 healthy subjects
(9males, 55±31years) were scanned at 7T and 3T, a
subgroup at 1.5 T (Siemens, Erlangen, Germany). Cine
imaging for the assessment of function and morphology
was performed at all field strengths (voxel size
1.4x1.4mm2 with slice thickness at 7T: 2,5mm and
4mm; at 3 and 1.5 Tesla with 6mm). Late gadolinium
enhancement (LGE) was performed at 3T for imaging of
fibrosis. Fat-water imaging techniques were employed at
1.5 T for fat analysis.
Results
All scans were successful and evaluable. At 3T LV quan-
tification were similar in short axis view and biplane
approach (LVEDV, LVESV, LVMASS, LVEF) (p=0.232;
p=0.437; p=0.549; p=0.118). There was no significant dif-
ference between 3T and 7 T (p=0.111; p=0.167; p=0.119;
p=0.204). Typical LGE was detected in 12/13 (92%)
HCM patients. High spatial resolution CINE imaging at
7.0 T revealed deep but small hyperintense myocardial
crypts in the regions for which LGE was detected at 3T.
Myocardial crypts occurred in 7/13(54%) of HCM
patients. The presence of fat was excluded as a cause for
the hyperintense signal. No crypts were detected for 2D
CINE imaging at 3T.
Conclusions
7 Tesla MRI is feasible in patients with HCM. High spatial
resolution CINE imaging at 7.0 T affords the detection of
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Table 1 Comparison of LV-function at different field
strengths
Mean 3T (biplane) 7T (biplane) p-value
LVEDV (ml) 139.9 136.7 0.232
LVESV (ml) 53.0 51.2 0.437
LVM (g) 187.0 174.9 0.549
LVEF (%) 62.9 59.9 0.118
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